Keyphrases
Platelet Activation
100%
Thrombocytopenia
100%
Activation Mechanism
100%
Immune Thrombocytopenia
100%
Autoimmune Disease
60%
Platelets
60%
Autoantibodies
60%
Thrombotic Thrombocytopenic Purpura
40%
Complement Activation
20%
Most Common Form
20%
Molecular Mechanism
20%
Innate Immune Response
20%
Functional Traits
20%
Bleeding Events
20%
Thrombosis
20%
Adaptive Immune Response
20%
Platelet Activity
20%
Thrombotic Events
20%
Coagulation Activation
20%
Antiphospholipid Syndrome
20%
Damage-associated Molecular Patterns
20%
Heparin-induced Thrombocytopenia
20%
Low Platelet Count
20%
Vaccine Response
20%
Elevated Liver Enzymes
20%
Systemic Lupus Erythematosus
20%
Common Mechanisms
20%
Platelet Receptors
20%
Immune Complex
20%
Complement Factors
20%
Platelet Formation
20%
COVID-19 Vaccine
20%
Drug-induced Thrombocytopenia
20%
Platelet Clearance
20%
Complex Damage
20%
Thrombosis Risk
20%
Circulating Platelets
20%
Pattern Factor
20%
Low Platelets Syndrome
20%
Immunomodulatory Molecules
20%
INIS
antibodies
100%
thrombosis
66%
complement
66%
purpura
66%
diseases
33%
liver
33%
drugs
33%
damage
33%
risks
33%
receptors
33%
pathology
33%
reviews
33%
pathogenesis
33%
enzymes
33%
molecules
33%
clearance
33%
vaccines
33%
heparin
33%
lupus
33%
hemolysis
33%
covid-19
33%
Medicine and Dentistry
Platelet
100%
Thrombocyte Activation
100%
Idiopathic Thrombocytopenic Purpura
100%
Thrombocytopenia
71%
Autoantibodies
42%
Immunity
28%
Thrombosis
28%
Autoimmune Disease
28%
Innate Immunity
14%
Systemic Lupus Erythematosus
14%
Complement Activation
14%
Complement Factor
14%
Thrombocyte Receptor
14%
Adaptive Immunity
14%
Elevated Transaminases
14%
Antiphospholipid Syndrome
14%
Antigen Antibody Complex
14%
Pathogenesis of Autoimmune Disease
14%
Low Platelet Count
14%
Heparin-Induced Thrombocytopenia
14%
Thrombocytopoiesis
14%
Thrombotic Thrombocytopenic Purpura
14%
COVID-19 Vaccine
14%
Thrombocytopenic Purpura
14%
Biochemistry, Genetics and Molecular Biology
Thrombocyte Activation
100%
Idiopathic Thrombocytopenic Purpura
100%
Platelet
100%
Thrombocytopenia
62%
Autoantibodies
37%
Immunity
25%
Innate Immunity
12%
Complement Activation
12%
Thrombopoiesis
12%
Platelet Count
12%
Antigen Antibody Complex
12%
Adaptive Immunity
12%
Antiphospholipid Syndrome
12%
Elevated Transaminases
12%
Thrombotic Thrombocytopenic Purpura
12%
Heparin-Induced Thrombocytopenia
12%
Thrombocytopenic Purpura
12%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombocytopenia
100%
Idiopathic Thrombocytopenic Purpura
100%
Autoimmune Disease
60%
Autoantibodies
60%
Thrombosis
40%
Syndrome
20%
Systemic Lupus Erythematosus
20%
Complement Factor
20%
Thrombocyte Receptor
20%
Hypertransaminasemia
20%
Antiphospholipid Syndrome
20%
Heparin Induced Thrombocytopenia
20%
Thrombotic Thrombocytopenic Purpura
20%
COVID-19 Vaccine
20%
Thrombocytopenic Purpura
20%
Immunology and Microbiology
Thrombocyte Activation
100%
Platelet
100%
Idiopathic Thrombocytopenic Purpura
100%
Autoantibodies
37%
Autoimmune Disease
25%
Immunity
25%
Innate Immune System
12%
Antiphospholipid Syndrome
12%
Complement Factor
12%
Complement Activation
12%
Systemic Lupus Erythematosus
12%
Adaptive Immune System
12%
Platelet Count
12%
Immune Complex
12%
Pathogenesis of Autoimmune Disease
12%
Heparin Induced Thrombocytopenia
12%
Thrombopoiesis
12%
Thrombotic Thrombocytopenic Purpura
12%
COVID-19
12%